Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
198.64B
Market cap198.64B
Price-Earnings ratio
11.51
Price-Earnings ratio11.51
Dividend yield
4.00%
Dividend yield4.00%
Average volume
16.54M
Average volume16.54M
High today
$79.92
High today$79.92
Low today
$78.50
Low today$78.50
Open price
$79.06
Open price$79.06
Volume
34.05M
Volume34.05M
52 Week high
$134.63
52 Week high$134.63
52 Week low
$73.31
52 Week low$73.31

MRK News

Simply Wall St 3d
Merck Begins Phase 3 Trial Of Innovative Prostate Cancer Treatment

recently initiated the IDeate-Prostate01 phase 3 trial, dosing the first patient for its investigational drug ifinatamab deruxtecan, aimed at treating metastati...

Merck Begins Phase 3 Trial Of Innovative Prostate Cancer Treatment

Analyst ratings

62%

of 26 ratings
Buy
61.5%
Hold
38.5%
Sell
0%

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.